Volume 86, Issue 5 pp. 332-336
SPECIAL ARTICLE

Is there an alternative to centralization for pancreatic resection in New Zealand?

Todd Hore

Todd Hore

Department of General Surgery, Christchurch Hospital, Christchurch, New Zealand

Search for more papers by this author
Megan Thomas

Megan Thomas

Department of General Surgery, Christchurch Hospital, Christchurch, New Zealand

Search for more papers by this author
Lisa Brown

Lisa Brown

Department of General Surgery, Christchurch Hospital, Christchurch, New Zealand

Search for more papers by this author
Magdalena Sakowska

Magdalena Sakowska

Department of General Surgery, Christchurch Hospital, Christchurch, New Zealand

Search for more papers by this author
Saxon Connor

Corresponding Author

Saxon Connor

Department of General Surgery, Christchurch Hospital, Christchurch, New Zealand

Correspondence

Mr Saxon Connor, Department of Surgery, Christchurch Hospital, Christchurch 8140, New Zealand. Email: [email protected]

Search for more papers by this author
First published: 21 May 2014
Citations: 6
T. Hore FRACS, MBChB; M. Thomas MBChB; L. Brown MBChB; M. Sakowska MBChB; S. Connor FRACS, MBChB.
Part of this study was presented at the RACS 2013, Auckland.

Abstract

Background

Internationally pancreatic surgery has become increasingly centralized; however, geographical and population distribution within New Zealand (NZ) limits the practicalities of such an approach. The aim of this study was to review the short-term outcomes of patients undergoing pancreatic surgery by a single hepato-pancreato-biliary trained surgeon in a centre that would meet the minimum criteria set by the NZ National Standards but not necessarily the definition of a high-volume surgeon/centre.

Methods

A retrospective review of consecutive patients undergoing pancreatic resection within an enhanced recovery programme by a single surgeon between March 2005 and April 2013. Primary outcomes were 30-day morbidity and 90-day mortality.

Results

A total of 156 patients who underwent a pancreatic resection were included. Eighty-two (53%) patients underwent a pancreaticoduodenectomy. Forty-seven (30%) underwent a left pancreatectomy. Overall, 30-day morbidity was 64% and overall 90-day mortality was 2.6%. Overall median length of stay was 11 (3–140) days.

Conclusions

Acceptable outcomes have been achieved for patients undergoing pancreatic resection within a centre that meets the criteria proposed by the NZ National Standards for treatment of pancreatic cancer.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.